One of its targets is protein kinase C alpha encoded by PRKCA. Data from the World Health Organisation (WHO) pharmacovigilance database, Vigibase, was used to perform a disproportionality analysis of reports of AF events. This evidence concerns the gene PRKCA and atrial fibrillation.